Doxazosin Tablet
Product Images NDC 71335-0349

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-0349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Doxazosin Fig1)

This appears to be a summary table of effectiveness data from placebo-controlled trials for a medical treatment related to urology. The effectiveness of the treatment is measured by maximum flow rate and symptom score. The table includes data from three separate studies and reports on different parameters based on the dosage of medication given to patients. There is also mention of questionnaires used in two of the studies. However, the specific treatment and its effectiveness compared to placebo are not mentioned, so further context is needed to provide a useful description.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

FDA Label Image

Chemical Structure (Doxazosin Str)

FDA Label Image

Label (Lbl713350349)

This text is a label of a medication called Doxazosin Mesylate 4mg. It comes in a round, yellow tablet shape with the inscription "C4". The tablet is packaged by Bryant Ranck Prepack Bunbauk and contains 30 tablets per container. The medication should be stored at room temperature, between 20°-25°C (68°-77°F). The label also contains the NDC number for the medication, which is 7133503491013551001523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.